BIOLASE, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Concentrations (Tables)

Concentrations (Tables)

9 Months Ended

Sep. 30, 2017

Risks And Uncertainties [Abstract]

Summary of Net Revenue from Various Products

Revenue from the Company’s products for the three and nine months ended September 30, 2017 and 2016 are as follows:

	Three Months Ended								Nine Months Ended
	September 30,								September 30,
	2017				2016				2017				2016
Laser systems		58.6	%			71.9	%			61.3	%			68.7	%
Imaging systems		10.2	%			2.6	%			7.8	%			4.5	%
Consumables and other		16.2	%			12.4	%			16.0	%			13.5	%
Services		14.7	%			12.9	%			14.6	%			13.0	%
License fees and royalties		0.3	%			0.2	%			0.3	%			0.3	%
Total revenue		100.0	%			100.0	%			100.0	%			100.0	%